 Connection
Aravindhan Veerapandiyan to Dystrophin
This is a "connection" page, showing publications Aravindhan Veerapandiyan has written about Dystrophin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.855 |
|
|
|
-
Veerapandiyan A, Shashi V, Jiang YH, Gallentine WB, Schoch K, Smith EC. Pseudometabolic presentation of dystrophinopathy due to a missense mutation. Muscle Nerve. 2010 Dec; 42(6):975-9.
Score: 0.371
-
Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Guridi M, Murphy AP, Reid C, Wandel C, Asher DR, Darton E, Mason S, Potter RA, Singh T, Zhang W, Fontoura P, Elkins JS, Rodino-Klapac LR. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial. Nat Med. 2025 Jan; 31(1):332-341.
Score: 0.243
-
Saylam E, Aravindhan A, Stefans V, Veerapandiyan A. Pseudometabolic Presentation of Dystrophinopathy in a Family Due to a Rare Nonsense Mutation. J Clin Neuromuscul Dis. 2020 Jun; 21(4):245-246.
Score: 0.179
-
Baldi O, Kinnett K, Schrader R, Denger B, Truba N, Sorensen S, Veerapandiyan A, Colvin MK. Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy. Muscle Nerve. 2025 Mar; 71(3):377-383.
Score: 0.062
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|